QLT Provides Update on Its Proposed Acquisition of InSite Vision Incorporated
August 21, 2015 08:39 ET
|
QLT Inc.
VANCOUVER, British Columbia, Aug. 21, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite")...
QLT Provides Update on Merger With InSite Vision Incorporated
August 10, 2015 08:38 ET
|
QLT Inc.
VANCOUVER, British Columbia, Aug. 10, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite...
QLT Announces Second Quarter 2015 Results
July 30, 2015 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, July 30, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...
QLT Announces First Quarter 2015 Results
April 30, 2015 09:44 ET
|
QLT Inc.
VANCOUVER, British Columbia, April 30, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...
QLT Announces Fourth Quarter and Year End 2014 Results
February 26, 2015 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 26, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...
QLT to Appoint Glen Ibbott as Interim Chief Financial Officer
January 05, 2015 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Jan. 5, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Mr. Glen Ibbott has been appointed as the Interim Chief...
QLT Announces Results of Annual General Meeting of Shareholders
December 16, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 16, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is pleased to announce that, on a vote by ballot, the six incumbent directors...
QLT Announces Results From Proof-of-Concept Trial With Oral Synthetic cis-Retinoid (QLT091001) in Adult Subjects With Impaired Dark Adaptation and/or Impaired Low Luminance Vision
December 05, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 5, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from its multi-center, Phase 2a clinical trial of...
QLT Announces Departure of Chief Financial Officer
December 02, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 2, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Sukhi Jagpal, Chief Financial Officer of the Company, has...
QLT Announces Third Quarter 2014 Results
October 28, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Oct. 28, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...